Phosphatidylserine/Phosphatidylcholine Microvesicles Can Induce Preeclampsia-Like Changes in Pregnant Mice

ABSTRACT

We established a phosphatidylserine (PS)/phosphatidylcholine (PC) microvesicles-induced preeclampsia-like model in mice. PS/PC were prepared by mixing 80% PC and 20% PS, and suspended in 0.05 M Tris-HCl at a concentration of 10 mg/mL. One hundred microliters of PS/PC (n = 6) and saline as a control (n = 10) were injected in tail veins of Institute of Cancer Research (ICR) mice every day from days 5.5 to 16.5 of pregnancy. Systolic blood pressure (SBP) was measured by means of the tail-cuff method. On day 17.5, the mice were anesthetized by diethyl ether and euthanized with the collapse of the circulation by drawing blood from the heart. The animals were dissected and the fetuses and placentas removed. Fetal weight and placental weight were evaluated. Plasma antithrombin activity (AT), thrombin-antithrombin complex (TAT), platelet counts, and proteinuria were measured on day 17.5. Placentas were fixed in 4% paraformaldehyde for histologic studies. Statistical analysis was evaluated by analysis of variance and Welch’s t-test. Mice injected with PS/PC showed a significant elevation in SBP (124 versus 101 mm Hg; p < 0.001), a significant increase in TAT levels (23 versus 6.6 μg/L; p < 0.05), a significant decrease in platelet counts (88 versus 102 × 10¹⁰/L; p < 0.05), a decrease in AT, an increase in proteinuria, and a significant reduction in fetal weight (1.2 versus 1.3 g; p < 0.0001) and placental weight (0.13 versus 0.15 g; p < 0.001), compared with controls. Placentas of mice injected with PS/PC showed diffuse fibrin depositions in the labyrinth layer. We have demonstrated that the artificial PS/PC vesicles induce intrauterine growth restriction with elevations of SBP. The elevation of plasma TAT and the diffuse fibrin depositions in the placentas indicate enhanced thrombin formation, and the significant elevations of SBP indicate preeclampsia-like changes that can be induced by hypercoagulation in the placenta.

KEYWORDS

Phosphatidylserine (PS)/phosphatidylcholine (PC) - intrauterine growth restriction - hypercoagulation - hypertension - preeclampsia

REFERENCES

• 1 Mushambi M C, Halligan A W, Williamson K. Recent developments in the pathophysiology and management of pre-eclampsia.  Br J Anaesth. 1996;  76 133-138
• 2 Khatun S, Kanayama N, Belayet H et al.. The impact of vasoactive peptides on nitric oxide production in cultured sympathetic neurons.  Neuroscience. 1999;  93 605-609
• 3 Khatun S, Kanayama N, Belayet H et al.. Increased concentrations of plasma neuropeptide-Y in patients with eclampsia and preeclampsia.  Am J Obstet Gynecol. 2000;  182 896-900
• 4 Kobayashi T, Terao T. Preeclampsia as chronic disseminated intravascular coagulation.  Gynecol Obstet Invest. 1987;  24 170-178
• 5 Kobayashi T, Tokunaga N, Sugimura M et al.. Coagulation/fibrinolysis disorder in patients with severe preeclampsia.  Semin Thromb Hemost. 1999;  25 451-454
• 6 Kobayashi T, Tokunaga N, Sugimura M, Kanayama N, Terao T. Predictive values of coagulation/fibrinolysis parameters for the termination of pregnancy complicated by severe preeclampsia.  Semin Thromb Hemost. 2001;  27 137-141
• 7 Kobayashi T, Sumimoto K, Tokunaga N et al.. Coagulation index to distinguish severe preeclampsia from normal pregnancy.  Semin Thromb Hemost. 2002;  28 495-499
• 8 Kobayashi T, Tokunaga N, Sugimura M, Kanayama N, Terao T. Vasospasms are characteristic in cases with eclampsia/preeclampsia and HELLP syndrome: proposal of angiospastic syndrome of pregnancy.  Semin Thromb Hemost. 2001;  27 131-135
• 9 Kelton J G, Hunter D JS, Neame P B. A platelet function defect in pre-eclampsia.  Obstet Gynecol. 1985;  65 107-109
• 10 Norris L A, Bevers E M, Comfurius P, van Rijn J LML, Hemke H C, Zwaal R FA. Generation of prothrombin-converting activity and the exposure of phosphatidylserine on the outer surface of platelets.  Eur J Biochem. 1982;  122 429-437
• 11 Vogt E, Ng A K, Rote N S. A model for the antiphospholipid antibody syndrome: monoclonal antiphosphatidylserine antibody induces intrauterine growth restriction in mice.  Am J Obstet Gynecol. 1996;  174 700-707
• 12 Sugimura M, Su F, Kanayama N, Kobayashi H, Kobayashi T, Terao T. Anticoagulant activity in non-immunoglobulin fraction from plasma of patients with antiphospholipid syndrome.  Semin Thromb Hemost. 1998;  24 473-477
• 13 Miyazaki Y, Nomura S, Miyake T et al.. High shear stress can initiate both platelet aggregation and shedding of procoagulant containing microparticles.  Blood. 1996;  88 3456-3464
• 14 Abdul Halim M B, Kanayama N, Maradny E E et al.. Plasma P selectin (GMP-140) and glycocalicin are elevated in preeclampsia and eclampsia: their significance.  Am J Obstet Gynecol. 1996;  174 272-277
• 15 Weinstein L. Syndrome of hemolysis, elevated liver enzymes, and low platelet count: a severe consequence of hypertension in pregnancy.  Am J Obstet Gynecol. 1982;  142 159-167
• 16 Kobayashi T, Sugimura M, Naruse H et al.. Anticholinergics induce eclamptic seizures.  Semin Thromb Hemost. 2002;  28 511-514
• 17 Thiagarajan P, Tait J F. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles.  J Biol Chem. 1991;  266 24302-24307
• 18 Chap H J, Zwaa R FA, van Deenen L LM. Action of highly purified phospholipids on blood platelets. Evidence for an asymmetric distribution of phospholipids in the surface membrane.  Biochim Biophys Acta. 1977;  467 146-164
• 19 Bevers E M, Comfurius P, van Rijn J LML, Hemker H C, Zwaal R FA. Generation of prothrombin-converting activity and the exposure of phosphatidylserine on the outer surface of platelets.  Eur J Biochem. 1982;  122 429-437
• 20 Stuart M C, Bevers E M, Comfurius P, Zwaal R F, Reutelingsperger C P, Frederik P M. Ultrastructural detection of surface exposed phosphatidylserine on activated blood platelets.  Thromb Haemost. 1995;  74 1145-1151
• 21 Rosing J, Tans G, Govers-Reimslag W P, Zwaal R FA, Hemker H C. The role of phospholipid and factor Va in the prothrombinase complex.  J Biol Chem. 1980;  255 274-283
• 22 Kumar R, Béguin S, Hemker H C. The effect of fibrin clots and clot-bound thrombin on the development of platelet procoagulant activity.  Thromb Haemost. 1995;  74 962-968
• 23 Kinlough-Rathbone R L, Perry D W. Prolonged expression of procoagulant activity of human platelets degranulated by thrombin.  Thromb Haemost. 1995;  74 958-961
• 24 Siljander P, Carpen O, Lassila R. Platelet-derived microparticles associated with fibrin during thrombosis.  Blood. 1996;  87 4651-4663
• 25 Sugimura M, Kobayashi T, Shu F, Kanayama N, Terao T. Annexin V inhibits phosphatidylserine-induced intrauterine growth restriction in mice.  Placenta. 1999;  20 555-560
• 26 Shu F, Sugimura M, Kanayama N, Kobayashi H, Kobayashi T, Terao T. Immunohistochemical study of annexin V expression in placentae of preeclampsia.  Gynecol Obstet Invest. 2000;  49 17-23
• 27 Sugimura M, Ohashi R, Kobayashi T, Kanayama N. Intraplacental coagulation in intrauterine growth restriction: cause or result?.  Semin Thromb Hemost. 2001;  27 107-113
• 28 Perry K G, Martin J N. Abnormal hemostasis and coagulopathy in preeclampsia and eclampsia.  Clin Obstet Gynecol. 1992;  35 338-350
• 29 Rabiet M J, Plantier J L, Dejana E. Thrombin induced endothelial cell dysfunction.  Br Med Bull. 1994;  50 936-945
• 30 Maki M, Kobayashi T, Terao T et al.. Antithrombin therapy for severe preeclampsia: results of a double blind, randomized, placebo-controlled trial.  Thromb Haemost. 2000;  84 583-590
• 31 Kobayashi T, Terao T, Ikenoue T, Kajiwara Y, Maki M. Antithrombin therapy for preeclampsia.  Biomed Progress. 2003;  16 72-77
• 32 Kobayashi T, Terao T, Ikenoue T et al.. Treatment of severe preeclampsia with antithrombin concentrate: results of a prospective feasibility study.  Semin Thromb Hemost. 2003;  29 645-652